Diplomat Pharmacy Inc (DPLO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Diplomat Pharmacy Inc (DPLO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9848
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Diplomat Pharmacy Inc (Diplomat Pharmacy) is a specialty pharmacy services provider that offers personalized medication therapies and various other clinical services. It also provides pharmacy benefit management and customized care management solutions, including dispensing, delivery, dosing, and reimbursement of clinically intensive and high-cost specialty drugs. The company is licensed to dispense prescriptions in all the US states and territories. Diplomat Pharmacy’s solutions include patient care system, clinically based drug therapy management programs, counseling on adherence and side-effect management, drug-specific compliance programs, and clinical and administrative support services. It also provides financial assistance to patients and Hub Services for maintaining collaboration among participants in the specialty pharmacy system. Through Diplomat University, the company provides training to external professionals, including pharmacists, payors, pharmaceutical partners, and physicians, on the specialty pharmacy industry. Diplomat Pharmacy is headquartered in Flint, Michigan, the US.

Diplomat Pharmacy Inc (DPLO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Diplomat Pharmacy Raises USD198 Million in Public Offering of Shares 10
Diplomat Pharmacy Raises USD143 Million in IPO 12
Acquisition 13
Diplomat Pharmacy Acquires Burman’s Specialty Pharmacy for USD82.8 13
Diplomat Pharmacy Acquires BioRx 14
Diplomat Pharmacy Acquires MedPro Rx, Infusion Provider 16
Diplomat Pharmacy Inc – Key Competitors 17
Diplomat Pharmacy Inc – Key Employees 18
Diplomat Pharmacy Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Aug 06, 2018: Diplomat announces 2nd quarter financial result 21
May 07, 2018: Diplomat Announces Strong 1st Quarter Financial Results 23
Feb 26, 2018: Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance 25
Nov 06, 2017: Diplomat Announces Third Quarter Financial Results 27
Aug 07, 2017: Diplomat Announces Second Quarter Financial Results 29
May 08, 2017: Diplomat Announces 1st Quarter Financial Results 31
Feb 28, 2017: Diplomat Announces 4th Quarter and 2016 Year End Financial Results; Provides Initial 2017 Guidance 33
Jan 09, 2017: Diplomat Provides 2016 Financial Guidance Update 35
Corporate Communications 36
May 10, 2018: Diplomat Pharmacy Appoints Brian Griffin as Chief Executive Officer and Chairman of the Board 36
May 08, 2018: Diplomat Pharmacy in Final Stages of CEO Search Process 37
Jan 05, 2018: Diplomat Initiates CEO Transition; Reaffirms 2017 Guidance and Provides Preliminary 2018 Outlook 38
Aug 07, 2017: Diplomat Announces A New President 40
Jun 08, 2017: Jeff Park Elected to Diplomat Board of Directors 41
Apr 13, 2017: Diplomat Promotes Executive Jennifer Cretu 42
Apr 11, 2017: Diplomat Appoints New Chief Financial Officer 43
Apr 06, 2017: Dr. Regina Benjamin Appointed to Diplomat’s Board of Directors 44
Feb 14, 2017: Diplomat Enhances Corporate Governance With Appointment of Ben Wolin to Newly-Created Role of Lead Director 45
Government and Public Interest 46
Feb 21, 2018: Diplomat Managing Rising Drug Costs to Support Patients 46
Other Significant Developments 47
Apr 30, 2018: Diplomat Launches CastiaRx Industry-Leading Specialty Benefit Manager 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diplomat Pharmacy Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Diplomat Pharmacy Raises USD198 Million in Public Offering of Shares 10
Diplomat Pharmacy Raises USD143 Million in IPO 12
Diplomat Pharmacy Acquires Burman's Specialty Pharmacy for USD82.8 13
Diplomat Pharmacy Acquires BioRx 14
Diplomat Pharmacy Acquires MedPro Rx, Infusion Provider 16
Diplomat Pharmacy Inc, Key Competitors 17
Diplomat Pharmacy Inc, Key Employees 18
Diplomat Pharmacy Inc, Other Locations 19
Diplomat Pharmacy Inc, Subsidiaries 19

List of Figures
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Diplomat Pharmacy Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Diplomat Pharmacy Inc (DPLO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HST Global Inc (HSTC):企業の財務・戦略的SWOT分析
    Summary HST Global Inc (HST Global) is a biotechnology, health and wellness company that discovers and develops treatment for metabolic disorders including cancer and other life threatening illnesses. The company provides therapies for dysfunction, metabolic deficiencies, and disorders providing an …
  • Enviva Partners LP (EVA):企業の財務・戦略的SWOT分析
    Enviva Partners LP (EVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tree Top, Inc.:企業の戦略・SWOT・財務分析
    Tree Top, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tree Top, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Refresco Gerber B.V.:企業の戦略・SWOT・財務情報
    Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report Summary Refresco Gerber B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Valener Inc (VNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Valener Inc (Valener) is an investment holding company that focuses on the energy sector. Through its investments in energy portfolio, the company offers storage, distribution, transportation and allied energy services. The company has interest in Gaz Metro and is its limited partner. Gaz Me …
  • Tejas Networks Ltd (TEJASNET):企業の財務・戦略的SWOT分析
    Tejas Networks Ltd (TEJASNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • AMAG Pharmaceuticals Inc:企業の戦略的SWOT分析
    AMAG Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Ornua Co-operative Limited:企業の戦略・SWOT・財務情報
    Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report Summary Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • University of Copenhagen:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university’ services include graduate and undergraduate courses, research programs, master's programs, continuing education services, online courses, inter …
  • Continental AG:企業の戦略・SWOT・財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cynosure Inc (CYNO)-医療機器分野:企業M&A・提携分析
    Summary Cynosure Inc (Cynosure) develops, manufactures and markets aesthetic and medical treatment systems. The company’s light-based aesthetic treatment systems are used in the treatment of skin revitalization and scar reduction, hair removal, gynecology, pigmentation, tattoo removal, wrinkle reduc …
  • FPT Industrial SpA:企業の戦略的SWOT分析
    FPT Industrial SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • HSH Nordbank AG:企業の戦略・SWOT・財務情報
    HSH Nordbank AG - Strategy, SWOT and Corporate Finance Report Summary HSH Nordbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Belize Electricity Ltd:企業の発電所・SWOT分析2018
    Belize Electricity Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …
  • GCL-Poly Energy Holdings Ltd:発電所・企業SWOT分析
    GCL-Poly Energy Holdings Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Comision Federal de Electricidad:企業の戦略的SWOT分析
    Comision Federal de Electricidad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Uniper SE (UN01):企業の財務・戦略的SWOT分析
    Uniper SE (UN01) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • EndoStim Inc-医療機器分野:企業M&A・提携分析
    Summary EndoStim Inc (EndoStim) is a medical device company that offers therapeutic solutions. The company develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. It concentrates on the treatment of gastroesophageal reflux disease through el …
  • Shin-Etsu Chemical Co Ltd (4063):企業の財務・戦略的SWOT分析
    Shin-Etsu Chemical Co Ltd (4063) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆